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INTRODUCTION
The diverse techniques for manipulating the genetic materials of living organisms and 
for exploring the complex chemistry of biological systems for food and agriculture, 
medicine and therapeutics, and for other complex indeterminate ends is described 
as biotechnology.1 Generally, biotechnology is an umbrella term implicating diverse 
disciplinarily convergences ranging from molecular biology, genetics, genomics, 
pharmacogenomics, to other sub-sets and specific classifications such as agricultural 
biotechnology, plant biotechnology and marine biotechnology, to name a few.
One of the consequences of the prominence of biotechnology in the global 
knowledge economic order has been the shift in the direction of innovation from 
technological to life sciences inventions.2 This new emphasis on the life sciences and 
the resulting rise in biotechnological innovation underscores the interconnectedness 
between biological processes and socio-cultural relationships, especially in regard 
to the present focus on genetic resources in indigenous and local communities. By 
some accounts, well over 70% of global biological or genetic resources are located in
*© Oguamanam 2010
**LL.B., LL.M, Ph.D (British Columbia), Associate Professor & Director, Law and Technology 
Institute, Schulich School of Law, Dalhousie University, Halifax, N.S.
1 Chidi Oguamanam, “Agro-biodiversity and Food Security: Biotechnology and Traditional 
Agricultural Practices at the Periphery of International Intellectual Property Regime 
Complex” [2007] Mich. St. L. Rev. 215 at 22; see also Mark J. Fecenko, Biotechnology Law: 
Corporate-Commercial Practice (Markham, Ont.: Butterworths, 2002) at 6-7.
2 See generally Ikechi Mgbeoji and Byron Allen, “Patent First, Litigate Later! The Scramble 
for Speculative and Overly Broad Genetic Patents: Implications for Access to Health Care 
and Biomedical Research” (2003) 2 CJLT 83; see also Margo A. Bagley, “Patent First, Ask 
Questions Later: Morality and Biotechnology in Patent Law” (2003) 45 Wm. & Mary L. Rev. 
469.
indigenous and local communities across the globe. These communities are the centers 
of global biodiversity.3
Indigenous bio-cultural knowledge and insights relate to the immemorial but 
dynamic and generally informal experience of the members of indigenous and local 
communities (outside the Western industrialized societies) in dealings with the diverse 
genetic resources endemic to their ancestral homelands. In many ways, such epistemic 
orientation depict a worldview that is based on the sanctity of the ecological order as an 
aspect of indigenous and local communities environmental ethic and integral to their 
socio-economic survival. It also constitutes critical aspects of their self-determination. 
Indigenous knowledge and insights thereof are critical to the advancement of life 
sciences and biotechnology in our increasingly converging knowledge system.4 
Given the relationship of dependence between biotechnology, biodiversity, biological 
resources and associated knowledge in indigenous and local communities, the latter 
have become interested stakeholders not only in biodiversity conservation and the 
regulation of the biotechnology enterprise, but also in the allocation of their benefits. 
Efforts are currently underway to create a national and international framework for 
fair and equitable access to biological resources as well as a fair and equitable sharing 
of the benefit of innovations arising from dealings in genetic materials and associated 
indigenous knowledge under the rubric of access and benefit sharing (ABS).5
The recent international initiative for a global treaty regime on ABS presents 
a strategic opportunity for Canada to take the issue of ABS seriously. A tactical 
approach to ABS would recognize the immemorial custodial role of Aboriginal people 
in tending Canada’s biodiversity and the contributions of their indigenous knowledge 
in genetic research and bio-related innovation. Such an approach would also position 
Canada optimally as a user and provider of genetic resources. It would place Canada in 
a position of leadership as a credible broker around the hardened schism in the politics
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of ABS. Thus far, the politics surrounding ABS have pitted developed countries as the 
users, against developing countries as the providers of genetic resources. Canada has 
the opportunity to be in a position to demonstrate that the positions of user and provider 
of genetic resources are not mutually exclusive. That understanding is necessary for 
progress on a credible global ABS regime.
ABS: A MATTER FOR FAIRNESS AND EQUITY
Why has the language and imperative for fairness and equity been added into the 
biodiversity conservation lexicon? Briefly, it arises from a simple recognition of 
the fusion between biological diversity and indigenous knowledge. Also, it is part 
of the convergence in knowledge systems, especially given regard to the importance 
and attraction of indigenous bio-cultural knowledge and biological resources for 
modem biotechnology. In another way, it is a response to the dichotomy between the 
concentration of biological resources in the global south, home of many indigenous 
and local communities on the one hand, and the repository of the scientific and 
industrial infrastructure for their exploitation in the industrialized or global north on 
the other hand. The application of biotechnology in dealing with biological resources 
in indigenous and local communities inherently involves contact with associated 
indigenous knowledge.6 In practical terms, biotechnology has often been a site for 
the elaboration of the fluidity of boundaries across knowledge systems, especially in 
regard to aspects of western science and indigenous knowledge systems.7
THE CBD AND GLOBAL FRAMEWORK FOR ABS
Since 2000, the United Nations Convention on Biological Diversity embarked on a 
dedicated program through its Working Groups on ABS and on Article 8(j), with a view 
to a full realization and practical translation of the Convention’s objectives, especially 
as they relate to ABS and indigenous knowledge, in the context of biodiversity 
conservation. After more than one half decade of CBD’s initiatives on ABS, there has 
been a significant response to the subject of equitable ABS at many levels, particularly 
pursuant to the 2002 Bonn Guidelines on Access to Genetic Resources and Fair and  
Equitable Sharing o f  Benefits Arising Out o f  their Utilization.8
6 Reliance on insights from indigenous bio-cultural knowledge is a major cost-cutting 
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as Trapped Knowledge: Intellectual Property, Culture, Power and Politics” (2008) 11 J. W.I.P.
29 [Oguamanam, “Local Knowledge”].
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Resources and Fair and Equitable Sharing o f Benefits Arising Out o f their Utilization 
(Montreal: Secretariat of the Convention on Biological Diversity, 2002), online: CBD 
<http://www.cbd.int/doc/publications/cbd-bonn-gdls-en.pdf>.
The first level relates to the international arena where the CBD initiatives 
on ABS provide the impetus for convergences in multiple forums in which ABS 
is explored in varying degrees. For instance, at the WTO-TRIPS (Trade-Related 
Aspects of Intellectual Property Rights) Council, there is presently a proposal to 
entrench the ethics of Prior Informed Consent (PIC) and equitable benefit sharing in 
the TRIPS Agreement. Consequently, there is a push to amend the TRIPS Agreement 
to accommodate disclosure of origin of genetic resources and associated indigenous 
knowledge in patent applications. Sponsors of this amendment argue that it would 
ensure that TRIPS is aligned with the CBD objectives, as opposed to its current 
status of potentially undermining the CBD.9 At the World Intellectual Property 
Organization (WIPO), similar sentiments are being expressed under two significant 
frameworks. The first is under the auspices of the Intergovernmental Committee on 
Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore 
(IGC/GRTKF)10 and the second is via the WIPO Patent Agenda,11 specifically in the 
inchoate negotiation of an international patent law treaty for the harmonization of key 
aspects of patent law under the aegis of Substantive Patent Law Treaty (SPLT). Still 
under the international framework, the subject of ABS is also an integral part of a 
more enduring debate around farmers’ rights,12 which was reinvigorated following the 
2001 FAQ International Treaty on Plant Genetic Resources for Food and Agriculture
9 This amendment is proposed as article 29bis of TRIPS and is sponsored by a group of 
developing countries, including Brazil, China, Cuba, India, Pakistan, Peru, Thailand, 
Tanzania, Ecuador and South Africa with the tacit support of the African regional bloc. See 
International Centre for Trade and Sustainable Development, “Disclosure of Origin Again 
on the TRIPS Council Agenda” (2007) 7 Bridges Trade BioRes (16th Feb), online: ICTSD 
<http://ictsd.org/i/news/biores/9089>.
10 The IGC-GRTKF initiative, which came into effect in 2001, is WIPO’s “forum for 
international policy debate and development of legal mechanisms and practical tools 
concerning the protection of traditional knowledge (TK) and traditional cultural expressions 
(folklore) against misappropriation and misuse, and the intellectual property (IP) aspects of 
access to and benefit-sharing in genetic resources.” For history, details and the program of 
work of this initiative, see WIPO online: <http://www.wipo.int/tk/en>. On October 1, 2009, 
the WIPO General Assembly renewed the mandate of the IGC for the 2010-2011 biennium.
11 The WIPO Patent Agenda refers to the 2001 WIPO policy initiative for the harmonization 
of the international patent system for ease of access, certainty and uniformity of the patent 
process in substantive, procedural and other regards: Agenda for Development o f the 
International Patent System: Memorandum o f the Director General, UNWIPO, 34th Year, 
36th Mtg., WIPO Doc A/36/14, dated August 6, 2001, online: WIPO <http://www.wipo. 
int/edocs/mdocs/govbody/en/a_36/a_36_ 14,pdf>. See Sisule F. Musungu and Graham 
Dutfield, “Multilateral Agreements and a TRIPS-plus World: The World Intellectual Property 
Organisation -  WIPO”, (December 2003) Quaker United Nations Office, TRIPS Paper #3; 
see also Carlos Correa and Sisule F. Musungu, “The WIPO Patent Agenda: the Risks for 
Developing Countries”, T.R.A.D.E Working Papers 12 (South Centre: Nov. 2002) online: 
South Centre <http://www.southcentre.org/index.php?option=com_content&task=view&id 
=76&Itemid=279>.
12 See Chidi Oguamanam, “Intellectual Property Rights in Plant Genetic Resources: Farmers’ 
Rights and Food Security of Indigenous and Local Communities” (2006) 11 Drake J. Agric. 
L. 273 [Oguamanam, “Farmer’s Rights”].
(ITPGRFA)13 and the activities of the Consultative Group on International Agricultural 
Research (CGIAR).14
The second level relates to the emergence of many regional and national 
regimes on ABS, especially following the 2002 CBD Bonn Guidelines on ABS.15 In 
this regard, there are today at least four regional initiatives (African Union, Andean 
Pact, Central America, and the Nordic Region) on ABS.16 There are 96 country specific 
legislative initiatives on ABS pursuant to the CBD.17 The third level consists of mainly 
informal self-regulating initiatives by private corporations involved in bio-prospecting 
activities under diverse arrangements. Integral aspects of those arrangements include
13 Oguamanam, “Farmer’s Rights” ibid. On the treaty, see the International Treaty on Plant 
Genetic Resources for Food Agriculture, see online: Food & Agriculture Organization <ftp:// 
ftp.fao.org/ag/cgrfa/it/ITPGRe.pdf>  [ITPGRFA]
14 Online: Consultive Group on International Agricultural Research <http://www.cgiar.org/ 
index.html>.
15 Text of Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing 
o f Benefits Arising from their Utilization, online: CBD <http://www.cbd.int/decision/ 
cop/?id=7198>.
16 For example, the African Model Legislation for the Protection o f the Rights o f Local 
Communities, Farmers and Breeders, and for the Regulation o f Access to Biological 
Resources (OAU, Algeria, 2000) and the ASEAN Framework Agreement on Access to 
Biological and Genetic Resources, Draft Text, 24 February 2000, online: <http://www.gram. 
org/brl_files/asean-access-2000-en.pdf.> See Rafael T. Boza, “Protecting Andean Traditional 
Knowledge and Biodiversity Perspectives under the U.S.-Peru Trade Promotion Agreement” 
(2008) 16 Currents 76; Stephen R. Munzer and Phyllis Chen Simon, “Territory, Plants, and 
Land-Use Rights among the San of Southern Africa: A Case Study in Regional Biodiversity, 
Traditional Knowledge, and Intellectual Property” (2008-2009) 17 Wm. & Mary Bill Rts. 
J. 831; Kanchana Kariyawasam, “Access to Biological Resources and Benefit-Sharing: 
Exploring a Regional Mechanism to Implement the Convention on Biological Diversity 
(CBD) in SAARC Countries” (2007) 29 E.I.P.R. 325.
17 See CBD Database on ABS measures, online: CBD <http://www.cbd.int/abs/measures. 
shtml>.
Material Transfer Agreements (MTAs),18 the principles of PIC,19 MAT and other 
benefit-sharing schemes.
TOWARD A TREATY REGIME ON ABS
In order to better coordinate the multiplicity of ABS regimes, the 2002 Johannesburg 
World Summit on Sustainable Development (WSSD)20 underscored the imperative for 
a harmonized global regime on ABS. Building on that imperative, the 7th Conference 
of Parties Meeting (COP) of the CBD in 2004 mandated the Working Group on Access 
and Benefit Sharing (WG-ABS) “to elaborate and negotiate an international regime on 
access to genetic resources and benefit-sharing with the aims of adopting an instrument/ 
instruments to effectively implement the provisions in Article 15 and Article 8(j) of 
the Convention and the three objectives of the Convention.”21 Already, the United 
Nations has declared the year 2010 as the International Year of Biodiversity22 (IYB) 
“to increase understanding of the vital role that biodiversity plays in sustaining life 
on Earth”23 and the global efforts or strategies to combat loss of biodiversity. Given 
that ABS is one such strategy, the IYB signals a determination to step up efforts on 
ABS not only as a biodiversity conservation incentive but also as a way to support the 
sustainability of biotechnology activities. The prospect of a binding global treaty on 
ABS envisaged by the WSSD would mark a departure from the current global ABS 
framework which is driven by the voluntary 2002 Bonn Guideline on ABS.
18 Broadly, MTA governs the transfer of tangible research materials between the providers/ 
owners and parties involved in the use of the materials for research or other purposes. For 
the purpose of ABS, MTAs deal mainly with the transfer of biological materials, including 
genetic resources. MTAs constitute part of the protocols sanctioned by the Bonn Guidelines, 
supra note 8.
19 PIC, a principle recognized under the Bonn Guidelines, refers generally to the requirement 
that researchers and other stakeholders seek the consent of the producers or custodians of 
biological resources, including genetic materials, premised on full disclosure of all relevant 
information regarding the use of the materials. In other contexts, PIC refers to the ethical 
principle of obtaining important information on the basis of full disclosure. For example, under 
the 2000 Biosafety Protocol o f the CBD and the Rotterdam Convention on Prior Informed 
Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade, 
PIC is a protocol for the exchange of information regarding sensitive, hazardous or toxic 
materials such as living modified organisms, unhealthy or environmentally dangerous 
chemicals and the like.
20 The WSSD was held in Johannesburg, South Africa ten years after the United Nations 
Convention on the Environment in Rio (Rio Earth Summit); hence the WSSD was dubbed 
the Second Earth Summit or Rio+10. The WSSD is yet another milestone in the evaluation 
of global environmental policy since the 1972 United Nations Convention on the Human 
Environment in Stockholm. The significance of the WSSD decision on ABS resonates with 
the importance of ABS for global environmental strategy.
21 See COP 7 decision VII/19 at D. 1, online: CBD <http://www.cbd.int/decision/cop/?id=7756>; 
see also supra note 17 and accompanying text.
22 See online: CBD <http://www.cbd.int/2010/welcome/>.
23 See online: CBD < http://www.cbd.int/2010/about/>.
ABS: AS AN ACCOUNTABILITY INITIATIVE
Why are the leading industrialized countries of the world opposed to an ABS model for 
supervising their dealings in genetic resources and associated indigenous knowledge 
in the global South and remote indigenous and local communities? Without question, 
for these countries the ABS regime is an irritation to the extent that it is also an 
accountability regime that seeks to redress the imbalance of unidirectional transfers 
of genetic resources, wealth and knowledge of indigenous and local communities 
in the era of biotechnology. Leading biotechnology countries would prefer that the 
genetic resources and associated indigenous knowledge remain, as they had been, the 
common heritage of humanity, outside the realm of real or intellectual property claims 
and consequently freely accessible without inhibition. Ironically, at the same time as 
these countries desire access without inhibition, they deploy intellectual property, 
particularly the patent system, to exercise proprietary control over the outcome or 
benefits of their dealings with these freely obtained materials. In many narratives of 
this trend, which is generally depicted as ‘biopiracy’, the providers of genetic resources 
and associated indigenous knowledge are outraged that they are unable to afford the 
resulting drugs, seeds or agricultural products, as the case may be, from the genetic 
resources they have provided often in trust and good faith for the common good. This 
is more so where the resulting ‘innovation’ is readily associated with traditional bio- 
cultural knowledge of indigenous and local communities.
CANADA’S APPROACH TO ABS
Canada is one of the world’s leading industrialized countries. Its support for a 
harmonized universal regime of stronger intellectual property rights is evident in its 
status as a member of the exclusive club of industrialized countries (the Quad)24 that 
championed the establishment of the TRIPS Agreement. Contrary to the desire of 
developing countries, Canada aligned with the US, EU, Japan and Australia to shift 
the discussion on ABS from the TRIPS Council to the WIPO, thereby suppressing an 
opportunity to open up the WTO system (of which TRIPS is a part) to the subject of 
indigenous knowledge.25 In the elaboration of the WIPO Patent Agenda, mentioned 
above, Canada has shown a lack of commitment regarding the requirement of evidence 
of PIC and disclosure of source and origins of genetic resources and associated 
knowledge in patent applications. The overall implication of Canada’s disposition 
is that it considers its interests as better served as a user of genetic resources and a 
member of the biotechnology industrial complex. Consistent with its disposition at the 
international forums, at the domestic level, Canada’s commitment to ABS is far from
24 Comprising the United States, Japan, the European Union and Canada. See Peter Drahos 
and John Braithwaite, “Hegemony Based on Knowledge: The Role of Intellectual Property” 
(2003)21 LIC 204 at 210.
25 Many developed countries were inclined to have the issue of ABS resolved within the 
framework of TRIPS for at least two strategic reasons. The first reason was to open up TRIPS 
to the subject of indigenous knowledge it had totally ignored. The second was to make ABS 
the subject of possible sanctions under the WTO Dispute Settlement Resolution.
one of unequivocal support; even though it is a key party to the CBD and host of its 
secretariat. The unwritten but compelling interpretation of Canada’s approach is that 
ABS is, at best, a developing country or indigenous people’s issue.
Despite the rise in country-specific regimes on ABS pursuant to the CBD, 
currently in Canada there is no specific ABS framework; even though “some laws and 
regulations in different jurisdictions cover some elements of ABS (e.g., permitting 
for the collection of genetic resources in national parks), but again, no common 
framework exists.”26 However, since 2004 Canada has engaged in a number of 
intergovernmental and cross-sectoral consultations, workshops and diverse activities 
aimed at formulating a Canada-wide ABS policy. In 2005, Canada issued a document 
titled: ABS Policies in Canada: Scoping the Questions and Issues.27 This was 
followed by a 2006 document titled Guiding Principles and Features o f  ABS Policies 
in Canada.28 The latter document is designed to “serve as a foundation for moving 
the policy discussion forward within jurisdictions and with stakeholders.”29 Also, it 
is projected as “create[ing] a balance between environmental, economic, social and 
legal considerations.”30 To date, Canada appears to have merely broached the complex 
nature of the issues involved in ABS, especially as it relates to Aboriginal peoples 
and their knowledge systems, often through government sponsored a d  hoc workshops 
designed to satisfy the Aboriginal stakeholder consultation component.
At the Canadian federal government level, there is already an emerging 
bureaucracy on ABS, pursuant to the CBD framework, in Environment Canada, through 
which Aboriginal stakeholders are required to navigate.31 But in all of these, the subject 
of ABS has yet to translate or crystallize into any concrete or substantive legislative 
outcome in accordance with international and national trends. Even conceding the 
historical, political and jurisdictional complexity of the Canadian national context 
in regard to the issue of genetic resources, indigenous people and knowledge, this 
state of motion without movement on ABS in Canada reflects Canada’s lackluster 
approach to the subject. A logical conclusion is that on the subject of the intersection
26 UNEP Convention on Biological Diversity, 5th Mtg., UNEP/CBD/WG-ABS/5/INF/2 
(2007), online: Convention on Biological Diversity <http://www.cbd.int/doc/meetings/abs/ 
abswg-05/information/abswg-05-inf-02-en.pdf>.
27 Federal/Provincial/Territorial Working Group on Access and Benefit Sharing of Genetic 
Resources, ABS Policies in Canada: Scoping the Questions and Issues (November 2005) 
online: Environment Canada <http://www.ec.gc.ca/apa-abs/documents/ABS_policies_e. 
pdf>.
28 Guiding Principles and Features o f ABS Policies in Canada, online: WIPO <http://www. 
wipo.int/export/sites/www/tk/en/laws/pdf7canada_abs.pdf>.
29 UNEP, supra note 26 at 15.
30 Ibid.
31 For instance, under Environment Canada there is an ABS Secretariat which serves as 
Canada’s National Focal Point (NFP) on ABS; there is also an office of Biosafety and ABS, 
Ecosystem and Biodiversity Priority Division and a CBD Office, in the Genetic Resources 
Unit.
between biodiversity, biotechnology and indigenous knowledge, Canada is beholden 
to its biotechnology industrial complex and has shied away from critically optimizing 
its peculiar position as not only a user but also as a provider of genetic resources 
and associated indigenous knowledge. As the international community commences 
a transition from the optional Bonn ABS guidelines toward a binding instrument on 
ABS, there is an opportunity for Canada to rearticulate itself and to revisit its current 
approach to ABS for a number of reasons.
A USER AND PROVIDER OF GENETIC RESOURCES
There are a number of bases upon which Canada can stake its claim as both a user and 
provider of genetic resources-a status that requires a more proactive approach to ABS. 
Without question, Canada’s status as a user of genetic resources is a given in light of 
its profile as a global player in biotechnology and related industries. Here, I highlight 
a few of those reasons that speak to Canada as a provider of genetic resources without 
being exhaustive. First, compared to the United States, Japan and most countries of 
the European Union, Canada has a significant number of Aboriginal people32 who are 
immemorial custodians of genetic resources and associated indigenous knowledge. 
Aboriginal people constitute almost 4% of Canada’s population.33 Along with other 
indigenous peoples of the Americas and the United States, Canada’s Aboriginal people 
are custodians of a strong historical cultural heritage and distinct identity rooted in 
pre-colonial and pre-conquest experience. That experience continues to be negotiated 
in the post or neocolonial era as a complementary feature of Canada’s national 
experience.
Second, Canada is the world’s second largest country, after Russia. It sits on 
9.9 million sq. km (3.8 million sq. miles) and, a fact unknown to many, is larger than 
the United States. An estimated 90% of Canadians live within 200km of the US border, 
leaving incredibly large expanses of wilderness and forest biodiversity to the north.34 
The diversity of Canada’s Aboriginal civilization is, in part, a factor of Canada’s diverse 
ecological setting and complex geographical composition. Ethnographers identify in 
Canada six of the ten geographical regions and cultural areas having shared cultural 
traits amongst indigenous peoples of the Americas. They are the arctic, subarctic, 
northwest coast, northeast woodlands, plains and plateau.35 As historical custodians of
32 Comprising First Nations’ descendants, Métis and Inuit.
33 According to Statistics Canada, in the 2006 census, at 1,172,790 the total “Aboriginal identity 
population” was 3.8% of Canada’s total population of 31, 241,030. Aboriginal People’s 
Highlight Tables, 2006 Census, online: Statistics Canada <http://wwwl2.statcan.ca/english/ 
census06/data/highlights/aboriginal/>.
34 Canada. (2010) The World Factbook, online: Central Intelligence Agency <https://www.cia. 
gov/library/publications/the-world-factbook/geos/ca.html> [World Fact Book].
35 Canadian Museum of Civilization, Gate Way to Aboriginal Heritage, Cultural Areas Index, 
2006, online: Museum of Civilization <http://www.civilization.ca/cmc/exhibitions/tresors/ 
ethno/etbO 170e.shtml>.
Canada’s diverse geographic and ecological space, in terms of their cultural practices 
and ecological centered epistemic outlook, Aboriginal people are a critical and integral 
part of Canada’s potential claim to being a user and provider of genetic resources and 
associated indigenous knowledge.
Third, Canada is an incredibly diverse country that is built largely on 
immigration. It is home to many cultures and peoples who bring with them a wealth 
of local knowledge from the most remote parts of the world and are capable of placing 
Canada in a position of strength within the cosmopolitan character of the new global 
knowledge economy.
Fourth, as “an affluent, high-tech industrial society,”36 the resilience of 
Canada’s economy lies in its diversity. For instance, in addition to exports of energy, 
machinery and equipment, Canada exports forestry, agricultural and fish products. 
Canada’s ability to exploit its biotechnology potential (for example in forestry, 
agriculture and aquatic resources) derives from its diverse ecological landscape 
which is fused with the diversity of its Aboriginal communities and their knowledge. 
In a way, a significant part of Canada’s biotechnology activities benefit directly or 
indirectly from Aboriginal plant, animal, marine, aquatic and forest genetic resources 
and associated knowledge. Thus, although Canada may not be a mega-biodiversity 
hotspot,37 like the Caribbean Islands, the Amazon, the Himalayas or Madagascar, it has 
vast nature and biosphere reserves, wilderness areas, wetlands, a significant collection 
of higher plants, mammals, breeding birds, reptiles, amphibians and fish. Apart from 
historic Aboriginal land claims that incorporate some of these resources, indigenous 
knowledge also constitutes an important aspect of immemorial Aboriginal stewardship 
in sustaining Canada’s biodiversity, and unique ecological, land and seascapes.
CONCLUSION 
ABS: A Strategic Opportunity for Canada
As negotiations get underway toward an international treaty regime on ABS, Canada 
has an opportunity to exchange its lukewarm disposition for a proactive approach to the 
subject. Specifically, as I have noted in the foregoing paragraphs, there are empirical 
reasons in support of a change in the Canadian attitude to ABS. Perhaps equally 
important are the strategic reasons for such a change. These differing foundations of 
support are not mutually exclusive. The strategic reasons have national and global 
ramifications. In regard to the national ramification, it is palpable that by casting itself 
as mainly a biotechnology country and consequently a user rather than a provider 
of genetic resources and associated indigenous knowledge, Canada alienates its
36 World Fact Book, supra note 34.
37 Biodiversity hotspots are sites with very highly populated and delicate collections of endemic 
species. Scientists believe that such sites are home to nearly 60% of the world’splant, bird, 
mammal, reptile, and amphibian species. There are more than 30 such hotspots globally.
Aboriginal peoples. As well, Canada undermines its stock of biodiversity and wealth 
of genetic resources. Without question, so far, there is no unity of purpose between 
the Canadian official position on ABS and the expectations of its Aboriginal people. 
There is, however, plenty of distrust. Not only does Canada’s approach demonstrate 
some insensitivity to the contributions of indigenous knowledge in the advancement 
of biotechnology, it also shows a lack of appreciation of the complex epistemic context 
for the practice of biotechnology.38 Also, this lackluster approach to ABS demonstrates 
a failure to grasp the significance of Canada’s extreme environments and complex 
ecological setting, including its rich forest resources. These factors make Canada an 
important repository of biodiversity and a significant site for bioprospecting and marine 
scientific knowledge and research. As the traditional notion of biodiversity adjusts to 
incorporate the realms of marine genetic resources (MGRs), Canada assumes a new 
significance in the biodiversity and ABS equation as a user and provider of genetic 
resources.
Overall, the exclusion of Aboriginal perspectives in the elaboration of ABS is 
problematic in regard to issues of both justice and of the valuing of diverse perspectives 
as an integral part of the Canadian national experience. Particularly, it represents a lost, 
but potentially salvageable, opportunity to strategically locate Canada as not only a 
biotechnologically strong country and, consequently, as a resource user but also as a 
provider of genetic resources and the associated indigenous knowledge of Canada’s 
diverse Aboriginal peoples. A more accommodating Canadian approach to ABS has 
the potential to restore the confidence of its Aboriginal peoples by providing them 
the required opportunity, like their counterparts elsewhere, to stake their claims and 
contributions to the global basket of knowledge in an era of biotechnology. Such an 
approach will assist in optimizing Canada’s potential on two critical counts: as user 
and producer of genetic resources which are serviced by a plural epistemic experience.
In regard to the global ramification, Canada’s unique position as both a 
leader in the field of biotechnology and a country rich in diverse genetic resources and 
Aboriginal or indigenous knowledge systems, can be leveraged through a strategic 
policy on global ABS movements. A position that is both sympathetic to users and 
providers of genetic resources and associated knowledge is one more likely to earn 
the confidence and sympathy of many developing counties. The current stalemate on 
the issues of PIC and disclosure of source of origin of genetic resources in the several 
deliberations at the TRIPS Council, WIPO, CBD and elsewhere is occasioned, in part, 
by hardened alignments of actors along two extremes: as users or as providers of 
genetic resources. There is hardly a middle ground. As a user and provider, Canada is 
capable o f presenting a measured perspective on ABS that represents the much needed 
middle ground for mediating negotiations on ABS for developed and developing 
country stakeholders.
38 For the relationship of dependence between biotechnology and local knowledge, see 
Oguamanam, “Farmer’s Rights,” supra note 12 at 275.
